We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CACLP 2025 New Date and Venue Announced

By LabMedica International staff writers
Posted on 16 Oct 2024

The 22nd China International In Vitro Diagnostic Expo, organized by the China Association of Clinical Laboratory Practice Expo (CACLP, Shanghai, China), is set to take place from March 21 to 24, 2025, in Hangzhou, China. Following the impressive numbers recorded by CACLP 2024, the upcoming event will return to provide global participants with a convenient and enriching experience at the newly inaugurated Hangzhou Grand Convention & Exhibition Center.

Situated in the economically dynamic Yangtze River Delta, Hangzhou boasts convenient transportation, advanced innovation, and a wealth of natural and cultural resources. This charming city creates an ideal environment for the in vitro diagnostic (IVD) industry. Hangzhou has 6,626 medical and healthcare institutions, which include 414 hospitals and 27 top-tier (Grade A, Level 3) hospitals. Moreover, Hangzhou has established China’s first dedicated IVD industry promotion institute to support local industry development. With China’s favorable visa-free policy, international participants will find it easier than ever to attend and explore an optimal setting for collaboration, networking, and the latest market trends and innovations.


Image: CACLP 2025 will return on 21-24 March 2025 to attract professionals across the IVD industry (Photo courtesy of CACLP)
Image: CACLP 2025 will return on 21-24 March 2025 to attract professionals across the IVD industry (Photo courtesy of CACLP)

CACLP 2024 was a remarkable success, showcasing a wide range of products and technologies from participants. The event, which took place in March 2024, attracted 1,346 exhibitors and 42,751 visitors from China and 40 other countries, all gathered in a vast area of 130,000 square meters. A series of academic activities featured 125 scientific lectures presented by 315 academic speakers, drawing over 5,000 delegates. These activities received 462,150 online views via CACLP's WeChat channels and app.

Following the success of CACLP 2024, numerous professionals across the IVD industry are expected to participate in the concurrent academic activities during CACLP 2025. These include the 10th China Experimental Medicine Conference (CEMC) and series sessions, as well as the 12th China IVD Industry Development Conference (CIIDC) and series forums. These activities will encompass in-depth discussions on current hot topics in laboratory medicine and IVD, with renowned experts and scholars presenting cutting-edge research findings, while industry leaders share valuable experiences.

Related Links:
CACLP


New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
C. difficile Positive Control
C. difficile Ag Positive Control for Rapid Test
New
Electroporation System
Gibco CTS Xenon

Latest Industry News

OraSure Technologies Acquires Sherlock Biosciences

Worldwide Initiative Aims to Develop Globally Generalizable Blood-Based Tests for Alzheimer’s Disease

Hologic Enters into Agreement with CDC for H5N1 Bird Flu Test Development